Assuming news is required, the following results were found.

  • #ECTRIMS2019 - Longer DMT Use and Female Sex Seen to Protect Against SPMS Conversion - Multiple Sclerosis News Today

    Women with multiple sclerosis (MS), and people who stay in a relapsing stage or use disease-modifying therapies (DMTs) for longer periods are less likely to transition to secondary progressive multiple sclerosis (SPMS) than others, according to a study...

    https://mschristian.org/index.php/blog/ectrims2019-longer-dmt-use-and-female-sex-seen-to-protect-against-spms-conversion-multiple-sclerosis-news-today
  • #ECTRIMS2019 - Transplanting MSCs Safe, Helps Stop Progressive MS - Multiple Sclerosis News Today

    Transplanting mesenchymal stem cells (MSCs) is safe and can delay disease progression in people with active, progressive multiple sclerosis (MS), according to results from a single-center clinical trial conducted in Israel. Six months after the...

    https://mschristian.org/index.php/blog/ectrims2019-transplanting-mscs-safe-helps-stop-progressive-ms-multiple-sclerosis-news-today
  • GW Pharmaceuticals’ Cannabis-Based Epilepsy Drug Sales Grow - Barron's

    million in the December quarter and $296 million in 2019—its first year of sales. Its stock (ticker: GWPH) rose 5% on the news, to $113.31. Its preannounced sales for the fourth quarter were somewhat better than predicted by admirers like Guggenheim’s...

    https://mschristian.org/index.php/blog/gw-pharmaceuticals-cannabis-based-epilepsy-drug-sales-grow-barron-s
  • Alzheimer’s Vaccine; Parkinson's PET Tracer; Fitness and Cognition

    F18, a PET tracer to help see damaged or lost nerve cells in people with Parkinsonian syndromes. (Radiology Business News) Infants breastfed by mothers who used antiepileptic drugs had substantially lower concentrations of antiseizure medications in...

    https://mschristian.org/index.php/blog/alzheimer-s-vaccine-parkinson-s-pet-tracer-fitness-and-cognition
  • Juul Labs taps Cartwright to lead restructuring team; promotes Sinha as interim CFO

    Chief Accounting Officer Saurabh Sinha as interim CFO, the spokesman added, according to the story. Category: Breaking News Original link Original author: GTNF Trust January 8, 2020 E-cigarette maker Juul Labs Inc has named Chief Financial Officer Guy...

    https://mschristian.org/index.php/blog/juul-labs-taps-cartwright-to-lead-restructuring-team-promotes-sinha-as-interim-cfo
  • NMSS updates - Key MS Policy Priorities Funded for FY 2020

    Society’s advocacy priorities, please click here. information source: https://www.nationalmssociety.org/About-the-Society/News/Key-MS-Policy-Priorities-Funded-for-FY-2020 Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews...

    https://mschristian.org/index.php/blog/nmss-updates-key-ms-policy-priorities-funded-for-fy-2020
  • BAT asked to end advertising of vapor products on social media app in UK

    Mark Hurley, director of internationalcommunications for the Campaign for Tobacco-Free Kids. “While the ASA ruling is great news, urgent policy change is needed from Facebook, Instagram and Twitter to prevent BAT and other tobacco companies from using...

    https://mschristian.org/index.php/blog/bat-asked-to-end-advertising-of-vapor-products-on-social-media-app-in-uk
  • Suicide Rate Almost Double in Patients With MS

    of the increased suicide risk and the risk for suicide attempts among these patients," Dr Brenner told Medscape Medical News. "It's very important to include screening measures for mental health in clinical practice." As well as depression, which is...

    https://mschristian.org/index.php/blog/suicide-rate-almost-double-in-patients-with-ms
  • Dr. Brian Cole Implements New Wound Closure Innovation To Ease And Improve Healing - P&T Community

    CHICAGO, Dec. 2, 2019 /PRNewswire/ -- Midwest Orthopaedics at Rush (MOR) is the first in the Chicago area to utilize a new wound closure technology: Micro-Anchor Skin Closures by BandGrip, Inc. MOR and BandGrip have partnered to provide this new...

    https://mschristian.org/index.php/blog/dr-brian-cole-implements-new-wound-closure-innovation-to-ease-and-improve-healing-p-t-community
  • Morning Break: 25 Measles Deaths in Samoa; Shady Stem Cell Clinics; Four Bad Practices

    cancers and immune disorders, but that hasn't stoppedso-called "stem cell clinics" from offering unapproved treatments. (NBC News) The Washington Post digs into a medical mystery of a Virginia teacher who seemed to have a respiratory infection, but then...

    https://mschristian.org/index.php/blog/morning-break-25-measles-deaths-in-samoa-shady-stem-cell-clinics-four-bad-practices
  • Cigarette smoking prevalence continues historic decline

    of some products go up while others go down, particularly among the young adult population,” said King. Category: Breaking News Original link (Originally posted by GTNF Trust) November 19, 2019 In its annual study released on Nov. 14, the U.S. Centers...

    https://mschristian.org/index.php/blog/cigarette-smoking-prevalence-continues-historic-decline
  • Overcoming obstacles earns SUNY Oswego freshman statewide scholarship - NNY360

    and achievements resulted in her becoming one of five statewide recipients of the Carey Gabay Scholarship Program. Johnson Newspapers 7.1 Latest News Most Popular Classifieds Original link Buy Now Buy Now SUNY Oswego freshman Samia Montgomery’s...

    https://mschristian.org/index.php/blog/overcoming-obstacles-earns-suny-oswego-freshman-statewide-scholarship-nny360
  • Potential genetic markers of multiple sclerosis severity

    NEWS RELEASE 31-OCT-2019 In a bid to determine factors linked to the most debilitating forms of multiple sclerosis (MS), Johns Hopkins Medicine researchers say they have identified three so-called "complement system" genes that appear to play a role in...

    https://mschristian.org/index.php/blog/potential-genetic-markers-of-multiple-sclerosis-severity
  • The maker of the first CBD drug isn't stopping with seizure treatment - STAT

    service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care...

    https://mschristian.org/index.php/blog/the-maker-of-the-first-cbd-drug-isn-t-stopping-with-seizure-treatment-stat
  • The MS Coalition invites you to join us for the 2019 Multiple Sclerosis Summit on Saturday, November 9, 2019 at the Westin Lombard, Illinois

    Sclerosis Foundation, National Multiple Sclerosis Society, United Spinal Association and associate member MS Views and News. Find the Multiple Sclerosis Coalition online at http://ms-coalition.org or visit MSC on Facebook and on Twitter @MS_Coalition....

    https://mschristian.org/index.php/blog/the-ms-coalition-invites-you-to-join-us-for-the-2019-multiple-sclerosis-summit-on-saturday-november-9-2019-at-the-westin-lombard-illinois
  • icometrix selected as one of the 150 most innovative digital health startups worldwide by CB Insights - PRNewswire

    NEW YORK, Oct. 2, 2019 /PRNewswire/ -- CB Insights today named icometrix to the inaugural Digital Health 150 ranking, showcasing the 150 most promising private digital health companies in the world. CB Insights CEO Anand Sanwal revealed the final...

    https://mschristian.org/index.php/blog/icometrix-selected-as-one-of-the-150-most-innovative-digital-health-startups-worldwide-by-cb-insights-prnewswire
  • In tiny doses, an addiction medication moonlights as treatment for chronic pain

    around, on the computer, able to do stuff.” This story is part of a partnership that includes KCUR, NPR and Kaiser Health News. This article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an...

    https://mschristian.org/index.php/blog/in-tiny-doses-an-addiction-medication-moonlights-as-treatment-for-chronic-pain
  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    Click here to subscribe to the MS Beacon e-Newsletter by MS Views and News Continuing Tysabri (natalizumab) treatment up to week 28 of pregnancy, and restarting soon after birth, reduces the risk of relapses in women with multiple sclerosis and appears...

    https://mschristian.org/index.php/blog/ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds
  • Upcoming MS Patient Round Table with Aaron Boster, MD, in Columbus, OH and another event in Louisville, KY

    will concern "MANY" affected by MS.. This event is on Thursday evening, December 5th. (www.events.msvn.org) - MS Views and News is providing this dinner event. -- Following this MS program, we will be driving to Louisville, KY to do another event on...

    https://mschristian.org/index.php/blog/upcoming-ms-patient-round-table-with-aaron-boster-md-in-columbus-oh-and-another-event-in-louisville-ky
  • MS Patients Should Be Informed about Pregnancy Risks and Family Planning, Experts Say

    SEPTEMBER 11, 2019 - BY ANA PENA, PHD of Medical News Today While pregnancy does not appear to affect the disease course of multiple sclerosis (MS), questions remain about the best time to stop or resume treatment before conception and after delivery,...

    https://mschristian.org/index.php/blog/ms-patients-should-be-informed-about-pregnancy-risks-and-family-planning-experts-say

Results 41 - 60 of 92
 
 

Follow Us on Twitter

Follow Us On Twitter - Image